Stay informed with timely news, analysis, and insights on CTP reimbursement, legislation, and policy changes. Learn how evolving regulations may affect clinicians, providers, and patient access to care.
Estimates state that chronic wounds impact 10.5 million Medicare beneficiaries, amounting to approximately one in six in this population. Managing such wounds, oftentimes in complex patient scenarios, and in the context of multiple comorbid...
Estimates state that chronic wounds impact 10.5 million Medicare beneficiaries, amounting to approximately one in six in this population. Managing such wounds, oftentimes in complex patient scenarios, and in the context of multiple comorbid...
Jim McDannald, DPM, explains why practices overly dependent on a single payer or procedure are most vulnerable to reimbursement shifts—and how diversification, smart marketing, and building true profit centers can stabilize growth during...
Jim McDannald, DPM, explains why practices overly dependent on a single payer or procedure are most vulnerable to reimbursement shifts—and how diversification, smart marketing, and building true profit centers can stabilize growth during...
In this Q&A, a wound care clinician weighs in on where regulators are getting it right, where policies may go too far, and how payment reform could shift the focus from advanced therapies to true prevention.
In this Q&A, a wound care clinician weighs in on where regulators are getting it right, where policies may go too far, and how payment reform could shift the focus from advanced therapies to true prevention.
As regulatory scrutiny around skin substitutes accelerates, providers are facing increasingly aggressive audits from Medicare, state Medicaid programs, and private payers alike. According to healthcare attorney Davidson N. Brooks, evolving...
As regulatory scrutiny around skin substitutes accelerates, providers are facing increasingly aggressive audits from Medicare, state Medicaid programs, and private payers alike. According to healthcare attorney Davidson N. Brooks, evolving...
Understanding how Medicare decides whether something is covered, how it must be reported, and what it will pay may help stakeholders better understand the circumstances surrounding recent regulatory changes.
Understanding how Medicare decides whether something is covered, how it must be reported, and what it will pay may help stakeholders better understand the circumstances surrounding recent regulatory changes.
Multiple bills in the 119th Congress seek to reshape Medicare payment, coding, oversight, and access for skin‑substitute products and related advanced wound‑care therapies. This snapshot summarizes five relevant measures’ status as of January...
Multiple bills in the 119th Congress seek to reshape Medicare payment, coding, oversight, and access for skin‑substitute products and related advanced wound‑care therapies. This snapshot summarizes five relevant measures’ status as of January...
Test your knowledge on the latest legislation on skin substitute wastage. Which is true about regulations for wastage of skin substitutes, according to an early January 2026 update?
Test your knowledge on the latest legislation on skin substitute wastage. Which is true about regulations for wastage of skin substitutes, according to an early January 2026 update?
The US Department of Health and Human Services Office of Inspector General (OIG) is intensifying scrutiny of wound care spending, with skin substitutes emerging as a prominent area of concern. In its Fall 2025 Semiannual Report to Congress,...
The US Department of Health and Human Services Office of Inspector General (OIG) is intensifying scrutiny of wound care spending, with skin substitutes emerging as a prominent area of concern. In its Fall 2025 Semiannual Report to Congress,...
The CTP News Desk delivers fast, trusted news and expert insights on wound care reimbursement, policy, and legislative updates that impact clinicians, providers, and patients. We break down key topics such as CMS payment rules, the Clinical Trial Requirement Rule, coverage policies, and market trends—helping the wound care community understand how these changes affect the use of cellular and tissue-based products (CTPs) in clinical practice.
Through balanced reporting, stakeholder perspectives, and real-world analysis, we connect evolving reimbursement policy to its direct implications for patient care, clinical decision-making, and sustainable wound management programs.